weight gain with glp 1 GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 ✨ozempic✨ can (kinda) ruin

Circulation 141 , 940942 (2020)

The CRL also requested additional technical data on the final commercial product, which Orexo said was unexpected. The FDA previously rejected OX124 in April 2023, citing technical issues with the equipment used for the secondary packaging process. July 10 Product: Novo Nordisks insulin icodec Indication: Diabetes mellitus Novo Nordisk was hit with a rejection Wednesday for its once-weekly basal insulin icodec injection for the treatment of diabetes mellitus

The first oral GLP1 pill received FDA approval in December 2025, with introductory pricing as low as $149 per month for the lowest dose

At least for these two doctors, the trial period appears to be over